CVE-2026-100584
mediumOpenClaw is an npm-distributed agent runtime.
OpenClaw is an npm-distributed agent runtime. In versions >= 2026.2.26 and < 2026.7.1, PowerShell command analysis on Windows hosts running in exec allowlist mode could approve an exact executable resolved from PATH but subsequently execute a same-named executable located in the workspace directory. If lower-trust content can place an executable with an approved basename into an agent-writable workspace and steer an approved PowerShell command that uses a bare executable name, OpenClaw may run the workspace file instead of the allowlisted path, executing arbitrary code with the privileges of the Gateway or node-host user. The issue does not require replacement of the approved executable itself. Version 2026.7.1 contains a fix; as a workaround, avoid bare executable names in approved PowerShell commands and keep executable files out of agent-writable workspaces.
CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H Affected products
Not reported by the source (unknown — not "none").
Weakness classification (CWE)
Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.
Mitigation & advisories
No vendor advisory or patch reference tagged by NVD. Check the references below.
References
- https://github.com/openclaw/openclaw/security/advisories/GHSA-rgjw-6v73-php6 disclosure@vulncheck.com
- https://www.vulncheck.com/advisories/openclaw-before-2026.7.1-allowlist-bypass-via-workspa... disclosure@vulncheck.com
